| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.2B |
| Cost of Revenue | $0.6B | $0.6B | $0.5B | $0.5B | $0.4B | $0.4B | $0.4B | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $0.4B | $0.2B | $0.4B | $0.7B | $0.3B | $0.1B | $0.1B | $0.0B |
| EPS (Basic) | $3.54 | $1.50 | $3.71 | $6.07 | $2.97 | $1.24 | $0.96 | $0.41 |
| EPS (Diluted) | $3.54 | $1.50 | $3.70 | $6.04 | $2.96 | $1.24 | $0.95 | $0.41 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $9.0B | $8.9B | $9.4B | $9.3B | $8.0B | $7.2B | $6.7B | $6.2B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | $0.0B | $0.0B | $0.3B | $0.0B | $0.6B | $0.4B | $0.0B | $0.0B |
| Total Liabilities | $4.6B | $4.1B | $4.3B | $4.3B | $3.7B | $3.7B | $3.0B | $2.8B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $4.4B | $4.7B | $5.0B | $5.0B | $4.2B | $3.4B | $3.6B | $3.3B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.8B | $0.8B | $0.8B | $0.7B | $0.6B | $0.5B | $0.6B | $0.5B |
| Investing Cash Flow | $-0.5B | $-0.3B | $-0.1B | $-1.5B | $-0.8B | $-0.4B | $-0.8B | $-0.6B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $-0.3B | $-0.7B | $-0.4B | $0.1B | $0.4B | $0.3B | $0.2B | $-0.2B |